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Experimental  allergic  encephalomyelitis  (EAE),  a  prototype  autoimmune 
disease and a  promising  model system for study of the human  demyelinating 
diseases, can be induced by a  single injection of either nervous tissue homoge- 
nates or a  myelin basic protein (MBP) constituent of nervous tissue, combined 
with adjuvant (1, 2). A cell-mediated immune mechanism has been implicated 
in the pathogenesis of EAE since the transfer of this disease has been accom- 
plished with lymphoid cells from sensitized donors (3-7), in contrast to unsuc- 
cessful attempts using immune serum (8). Support for a T-cell-mediated immu- 
nopathogenesis has been reported recently by two groups of workers.  Gonatas 
and Howard (9) showed an inhibition of EAE development in B rats, viz., rats 
depleted of T  cells by thymectomy, irradiation,  and reconstitution  with bone 
marrow B celIs. Ortiz-Ortiz  and Weigle (10) extended this observation showing 
an  inhibition  of EAE  in rats  rendered  devoid of MBP-reactive T  cells,  while 
disease could be induced  in rats  devoid of MBP-reactive B  cells.  The  precise 
lymphoid cell subpopulation and/or cellular product(s) responsible for this dis- 
ease, however, are as yet undefined. 
In earlier investigations from this laboratory,  lymph node cells (LNC) from 
sensitized  Lewis  donor  rats  were  incubated  at  37°C  for  1-4  h,  washed,  and 
injected into Lewis recipients.  After incubation,  the capacity of these LNC to 
transfer  EAE  was  variably  diminished-an  effect best recognized  by lack  of 
disease in those recipients receiving small numbers of incubated donor LNC in 
contrast to successful transfer in other animals injected with equivalent num- 
bers of unincubated cells (11, 12). This finding suggested that during incubation 
of sensitized LNC, EAE transfer activity was either destroyed or such activity 
conceivably was released into the medium in which the suspended cells had been 
incubated. 
In preliminary  efforts to search for EAE transfer activity in sensitized LNC 
supernates,  such activity was only demonstrated  irregularly  and  occasionally 
(M.  M.  Ginsberg,  and P.  Y.  Paterson,  unpublished data).  The purpose of this 
report is to briefly summarize  a  relatively large number  of experiments  now 
completed, including key control groups of animals, which provide unequivocal 
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evidence for transfer  activity in supernates  derived from sensitized  lymphoid 
cells prepared  and incubated under the conditions described.l  For pu4"poses of 
convenience, we have termed such activity EAE supernatant  transfer activity 
(EAE-STA). 
Materials  and Methods 
Animals.  Male Lewis rats,  8-12  wk of age (Microbiological Associates,  Bethesda,  Md.  and 
Simonson  Laboratories,  Gilroy,  Calif.)  were  used  as  donors  and  recipients.  All animals  were 
maintained  on  Purina  Laboratory  Chow  (Ralston  Purina  Co.,  St.  Louis,  Mo.)  and  water  ad 
libitum. 
Sensitization of  Donor Animals.  Rats were irdected intracutaneously over the back and neck 
with guinea pig spinal cord (GPSC) (Pel Freeze Bio-Animals, Inc., Rogers, Ark., and Dutchland 
Lab. Animals; Denver, Pa.) plus complete Freund's adjuvant  (CFA) as previously described (13, 
14). Control donor rats included unsensitized rats and others sensitized with CFA only or guinea 
pig kidney and CFA. 
LNC Suspensions.  9 days after sensitization, the draining lymph nodes were excised, trimmed 
of fat, and expressed through a  stainless steel screen (120 mesh) with moderate pressure using a 
plastic syringe plunger. The dissociated LNC, suspended in Hanks' balanced salt solution (HBSS) 
without serum, were washed once and resuspended at the desired concentration in fresh HBSS. 
Control recipients received 5  ×  106 unincubated LNC via the lateral tail vein. 
Incubation of LNC Suspensions.  LNC suspensions marked for generation of EAE-STA were 
incubated  at  two  arbitrary  cell concentrations:  2.5  x  108  and  5.0  ×  108  LNC/ml.  These  cell 
suspensions  were incubated in a  37°C waterbath for 1 h  with gentle mixing at 10-rain intervals. 
After incubation, supernates were obtained by centrifugation (200 g, 20 rain) of the LNC suspen- 
sion and 2-4 ml supernate  injected intravenously into syngeneic recipients. In two experiments, 
the LNC incubation was carried out in the presence of lyophilized reconstituted  GPSC  (0.5  mg 
protein/ml) or GPSC was added at the same concentration to the supernate after incubation. 
Criterion for Transfer of  EAE.  Although recipient animals were observed for clinical signs of 
EAE, none appeared.  Lack of such signs was consistent with the previously reported rarity of 
neurologic signs in recipients of unincubated LNC (1, 3, 15, 16). 14-16 days after transfer, recipient 
animals  were sacrificed, and  their brains and  spinal  cords processed and sectioned for routine 
hematoxylin-eosin staining as described previously (15). In eight recipients of LNC supernate, 
other organs,  e.g. spleen, kidney, heart,  and liver, also were removed and processed for micro- 
scopic observation. 
Successful transfer of EAE was determined by the presence within the brain and/or spinal cord 
of focal perivascular  mononuclear  cell infiltrates characteristic  of the disease.  Histopathologic 
changes in each recipient were scored from 1+ to 3+ based on enumerated infiltrates observed in 
brain and spinal cord sections: 1 +, from 1-10 lesions; 2 +, from 11-30 lesions; and 3 +, greater than 
30 lesions. 
Results 
The results of 22 separate experiments are represented in Table I. As shown in 
the upper panel, supernates derived from incubated LNC transferred EAE to 24 
of 54 syngeneic recipients.  These 54 recipients  were employed in a  total of 19 
experiments,  in 11 of which transfer was successfully accomplished. Sections of 
i  For anyone wishing information concerning the experimental conditions we employed in 
greater  detail  than  space  permits  here,  a compilation  of  all  consumable  reagents,  including  source 
and lot numbers, and a detailed step-by-step  description  of all procedures is available.  This 
appendix is NAPS  document no. 02996 consisting  of 16 pages.  Order from ASIS/NAPS, Micro- 
fiche  Publications,  P. O. Box 3513,  Grand Central Station,  New York 10017.  Remit in advance 
$3.00 for microfiche copy or for photocopy, $5.00  up to 20 pages plus 25¢ for each additional 
page. All orders  must be prepaid.  Foreign  orders  add $3.00  for  postage and handling. WHITACRE  AND  PATERSON  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Transfer of  EAE with Sensitized LNC or Supernates Derived from Incubated 
Sensitized LNC 
1407 
Donor status 
Sensitization  Material transferred 
Proportion of recipients 
with lesions of EAE 
GPSC-CFA  Supernate*  24/54 
GPSC-CFA  Supernate plus brain anti-  0/8 
gen~ 
GPSC-CFA  5 × 10" unincubated LNC  36/40 
GPSC-CFA  5 x 10" incubated LNC  9/9 
CFA, kidney-CFA,  5 × 10' unincubated LNC  0/15 
or none  or supernate 
* Recipients received  2.0-4.0 ml supernate derived from a 1 h, 37°C incubation of a 2.5 x  10. or 5 ×  10" sensitized 
LNC/ml suspension. 
* Recipients received 4.0 ml supernate prepared either by incubation of donor LNC with brain antigen or by 
addition of brain antigen aiter incubation. 
spleen,  liver,  kidney,  and  heart  from some  of these recipients  injected  with 
supernates  and developing lesions of EAE,  had no significant  histopathologic 
changes.  The addition of brain antigen to active supernates,  also shown in the 
upper panel,  led to EAE-STA no longer being demonstrable. 
Shown in the lower panel of Table I are a  variety of control transfer experi- 
ments.  Transfer  of unincubated  LNC,  from the  same  pools of cells  used  for 
generation  of EAE-STA,  served as an index for degree of sensitization  of the 
donors. Such LNC, in relatively large numbers (500 x  106), as well as equivalent 
numbers of incubated LNC, transferred  EAE as described previously (3, 8,  11, 
12). Recipient rats receiving either LNC or supernates from donors sensitized to 
CFA  only,  guinea  pig  kidney  and  CFA,  or  left  unsensitized  developed  no 
evidence of EAE. 
Morphologically, the central nervous system perivascular infiltrates observed 
in recipients  of supernates  were indistinguishable  from cellular  infiltrates  in 
recipients receiving unincubated  LNC  (Fig.  1).  However, the total number of 
infiltrates in recipients injected with supernates was less than that in recipients 
of unincubated LNC, as judged by the average lesion scores: LNC recipients, 2.1; 
supernatant  recipients,  1.3.  The average lesion score was equally decreased in 
recipients of incubated LNC, viz.,  1.4. 
In preliminary efforts to begin characterizing the nature of EAE-STA, many 
questions immediately arose. For example, do active supernates contain intact 
LNC  in numbers  sufficient to account for transfer?  To  answer this  question, 
portions of several supernates were ultracentrifuged at 189,000 g for 1 h and the 
pellets examined for the presence of LNC. 2 Cell counts averaged less than 1.8 x 
104 LNC/ml of supernate or well below the minimal number of LNC reported to 
transfer EAE under the conditions employed in this laboratory (3). Is EAE-STA 
stable?  Two  separate  experiments  have  shown  that  after  freezing  of LNC 
2 One  pellet  was  examined  by  electron  microscopy  with  the  aid  of Dr.  Mauro  Dal  Canto, 
Departments of Neurology and Pathology, Northwestern University Medical School, Chicago, Ill., 
and found to contain material ranging from cell remnants to membrane fragments to intact cells. 
The presence of cell degradation  products suggests that the intact cells present are themselves 
unlikely candidates for the transfer activity demonstrated by LNC supernates. 1408  WHITACRE  AND  PATERSON  BRIEF  DEFINITIVE  REPORT 
Fro.  1.  Focal perivascular mononuclear cell infiltrates indicative of EAE in the mesen- 
cephalon of a  Lewis rat 16 days after a  single injection of sensitized LNC  supernate.  (A) 
Hematoxylin  and eosin  approximately  80x.  (B) The  most intense infiltrate shown in A 
(hematoxylin and eosin approximately 320 x ). 
supernates  (-20°C  for  48-72  h),  EAE-STA  was  no  longer  demonstrable.  An 
attempt to extract EAE-STA from unincubated sensitized LNC by four freeze- 
thaw cycles also proved unsuccessful. Does longer incubation time increase the 
yield of EAE-STA? Supernates obtained after 2, 3, or 4 h of incubation of sensi- 
tized LNC were devoid of EAE-STA. 
Discussion 
The  study here  reported  indicates  that  supernates  derived from incubated, 
sensitized  LNC  are  capable  of transferring  EAE  in  Lewis  rats.  EAE-STA 
appears to be an immunologically specific response to nervous tissue sensitiza- 
tion, since supernates derived from control donors (Table I) did not transfer. 
It  is  noteworthy  that  the  addition  of brain  antigen  to  active  supernates 
resulted in disappearance of EAE-STA. This is consistent with reports showing 
that sensitized LNC suspensions,  when incubated with brain antigen in vitro, 
lost the capacity to transfer  EAE  (11,  12). The fact that the addition of brain 
antigen  to active supernates as well as LNC suspensions results in decreased 
transfer activity suggests that '~antigen carry-oveff' and sensitization  of recipi- 
ents does not account for EAE-STA. 
The lack of EAE-STA in some experiments can be explained in at least two 
ways. In those experiments in which supernates did not transfer,  it was clear 
that  control  recipients  of unincubated  sensitized  LNC  had  markedly  fewer 
lesions compared to other controls in other experiments where EAE-STA was 
demonstrated.  Thus  suboptimal sensitization  of donors may well be a  factor. 
Second,  lability of EAE-STA,  suggested by preliminary  characterization  stud- 
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future experiments, complete characterization of the transfer activity may be a 
formidable undertaking. 
Results similar in principle to those reported here using a  different model 
system were described in 1967 by Guthrie et al.  (17). These workers demon- 
strated that incubation of sensitized guinea pig peritoneal exudate cells at 37°C 
for 30  min effected the release of a  supernatant factor which conferred upon 
recipients specific contact sensitivity to  1-fluoro-2,4-dinitrobenzene. Although 
the sensitizing antigen, the donor species, and the lymphoid cell population used 
by Guthrie et al.  (17) differed materially from those we used for generation of 
EAE-STA, their observation supports the validity of our finding. 
Our  studies  indicate  that  EAE,  previously transferred  only  with  viable, 
sensitized lymphoid cells,  can now be transferred with lymphoid cell-derived 
preparations. Hopefully, this supernatant transfer system will permit physico- 
chemical studies of the factor(s) responsible for EAE-STA and provide further 
insight into the immunopathogenesis of EAE. 
Summary 
Supernates derived from incubated lymph node cells of Lewis rats sensitized 
to  guinea  pig  spinal  cord-Freund's  adjuvant  transfer  experimental  allergic 
encephalomyelitis (EAE)  to  syngeneic recipients.  EAE  supernatant transfer 
activity (EAE-STA)  is not demonstrable in supernates derived from LNC of 
control donors not sensitized to nervous tissue. After addition of  brain antigen to 
active supernates, EAE-STA is no longer demonstrable. 
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